Dr. Amirali Popat

School of Pharmacy, The University of Queensland, Associate Professor

Associate Professor Amirali Popat is a NHMRC Career Development Fellow and Director of Research at The University of Queensland’s School of Pharmacy. He graduated with a PhD in Nanomedicine from Australian Institute of Bioengineering and Nanotechnology (AIBN), UQ in 2012. His research focuses on development of stimuli responsive nanomaterials to overcome multiple biological barriers for precision medicine, in particular development of smart oral drug delivery systems for the treatment of IBD, Diabetes and Cancer. He has published more than 50 papers and 3 patents in the last 10 years with > 2500 citations and H-Index of 25. At the School of Pharmacy, UQ Dr. Popat is heading a research group “Nanomedicine” which focuses on development of programmable drug delivery systems to treat chronic diseases such as IBD, Diabetes, and Cancer. Since 2020 he serves as a president of Australian Controlled Release Society (AusCRS) and academic board member of CRS focus group on nanoscale delivery. He is also an editorial board member of many prestigious journals such as Journal of Controlled Release, DDTR, Pharmaceutics and early career advisory board member of Nanoscale Horizon. ​
​
​


​Sessions
CRS IC Special Session

 

---